Outpatient treatment with lisocabtagene maraleucel (liso-cel) across a variety of clinical sites from three ongoing clinical studies in relapsed/refractory (R/R) large B-cell lymphoma (LBCL) Meeting Abstract
| Authors: | Bachier, C. R.; Godwin, J. E.; Andreadis, C.; Palomba, M. L.; Abramson, J. S.; Sehgal, A. R.; Hildebrandt, G.; Stevens, D. A.; Hoda, D.; Licitra, E. J.; Siddiqi, T.; Farazi, T. A.; Kostic, A.; Trede, N. S.; Wang, L.; Lymp, J.; Maloney, D. G. |
| Abstract Title: | Outpatient treatment with lisocabtagene maraleucel (liso-cel) across a variety of clinical sites from three ongoing clinical studies in relapsed/refractory (R/R) large B-cell lymphoma (LBCL) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 425s |
| Language: | English |
| ACCESSION: | WOS:000560368303257 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.8037 |
| Notes: | Meeting Abstract: 8037 -- Source: Wos |
